Evelo Biosciences Investor Relations Material
Latest events
Q4 2022
Evelo Biosciences
Q3 2023
9 Nov, 2023
Q2 2023
14 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Evelo Biosciences Inc
Access all reports
Evelo Biosciences, Inc. (EVLO) is a clinical-stage biotechnology company engaged in the discovery and development of novel oral medicines. These medicines are designed to act on immune cells within the small intestine, with the aim of achieving systemic effects. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the OTC markets.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
EVLO
Country
🇺🇸 United States